"These outstanding results have been made possible by i.v.STATION's cost advantage over IntelliFill -Vial Mode and RIVA [up to 20 times less expensive/per dose], its unparalleled flexibility in syringe and IV Bags brands and sizes [73 different IV containers versus 1 container for IntelliFill and 12 containers for RIVA, respectively], its built-in support for controlled substances [tamper-evident cap, biometric ID, and single slot/drawer access], its small footprint [20 vs. 200 sq. feet], its loading speed [up to 10 times faster], its lower weight (700 vs. 7,000 pounds], its high-availability [up to 99.99%], and its ultra-quick throughput [up to 5 times faster]. With McKesson Automation's technical support in the United States' beginning with our last two installations [MD Anderson and Cottage], we are ready to embark into the next phase of market adoption, showcasing i.v.SOFT and i.v.STATION as prime additions to our I.V. Room of the Future strategy, building upon CytoCare, the first and still only proven robotic solution for chemotherapy, monoclonal antibody therapy, and gene therapy. i.v.SOFT also has significant differences and proven design and 3-to-1 cost advantages over currently available systems, including its cable-less, light-weight, battery-operated and wireless architecture, medical-grade computing, gravimetric control, biometric [facial] identification, and waterproof anti-tampering cameras, all specifically designed for clean-room environments and its specific needs for sterilization, cleaning, wiping, etc." stated Werner Rainer, Health Robotics' CEO.
While most i.v.SOFT competitors' print the IV dose label before
compounding even starts [thus delivering a patient label printed before the
preparation is actually made and verified], and depend on a Technician's
self-documenting audit trail of their work, i.v.SOFT
|SOURCE Health Robotics|
Copyright©2010 PR Newswire.
All rights reserved